Skip to main content
. Author manuscript; available in PMC: 2019 Sep 18.
Published in final edited form as: Am J Surg Pathol. 2018 Aug;42(8):1059–1066. doi: 10.1097/PAS.0000000000001084

Figure 2. Heat map comparing PD-L1 SP263, SP142 and 22C3 antibody clones in urothelial carcinoma and hypopharyngeal squamous cell carcinoma.

Figure 2.

Blue: PD-L1-positive tumors using established clinical algorithms as summarized in table 1. Orange: PD-L1-negative tumors.